Entry Detail



General Information

Database ID:exR0012412
RNA Name:RPS4X
RNA Type:mRNA
Chromosome:chrX
Starnd:-
Coordinate:
Start Site(bp):72255679End Site(bp):72277248
External Links:ENSG00000198034



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AGPAT3
chr21
43865223
43987592
+
ALDOA
chr16
30064164
30070457
+
ACSL3
chr2
222860942
222944639
+
ADAR
chr1
154582057
154628013
-
ACAA1
chr3
38103129
38137242
-
AL022238.4
chr22
40346529
40410054
+
AL136454.1
chr1
192716132
192716653
+
ADSL
chr22
40346500
40390463
+
AKAP13
chr15
85380571
85749358
+
ADTRP
chr6
11712054
11807046
-
ADA2
chr22
17178790
17258235
-
ABCF2
chr7
151207837
151227166
-
AC026464.4
chr16
69299682
69322700
+
AC011530.1
chr19
45779437
45785973
-
AL590764.2
chrX
71103987
71111575
-
AKR1A1
chr1
45550543
45570049
+
AASS
chr7
122073549
122144255
-
AC245033.1
chr15
82536788
82573194
-
ADRM1
chr20
62302093
62308862
+
AC010422.3
chr19
12643831
12648397
-
ACAD9
chr3
128879596
128916067
+
ACKR3
chr2
236567787
236582354
+
AC010132.3
chr7
42909273
42932174
-
AC139530.2
chr17
81703371
81720539
+
ACAT1
chr11
108116695
108147603
+
AC120057.2
chr17
7240427
7244635
-
ACTB
chr7
5527148
5563784
-
ACIN1
chr14
23058564
23095614
-
AC104452.1
chr3
49416777
49429314
-
ACTG1
chr17
81509971
81523847
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-155-5p
chr21
25573983
25574006
+
hsa-miR-3651
chr9
92292461
92292484
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC006511.5
chr12
8014093
8019007
-
AC016876.2
chr17
7581964
7584086
-
AC020663.1
chr16
4730115
4752565
-
AC023509.1
chr12
53441741
53467528
+
AC087190.3
chr16
9104848
9113181
+
AC091564.7
chr11
6610883
6616594
-
AC107959.2
chr8
23068229
23083619
+
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL118506.1
chr20
63861212
63864293
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.